# Use of Clobazam for Epilepsy and Anxiety

> **NCT03371836** · PHASE4 · COMPLETED · sponsor: **Hugo W. Moser Research Institute at Kennedy Krieger, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Epilepsy
- Anxiety

## Interventions

- **DRUG:** Clobazam

## Key facts

- **NCT ID:** NCT03371836
- **Lead sponsor:** Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371836, "Use of Clobazam for Epilepsy and Anxiety". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03371836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*